Coatings for stents that include a polymer and a drug are provided. The stent's struts are generally linear segments interrupted by a curved or bent segment that contain a drug/polymer coating wherein the concentration of the drug in the coating is greater in at least a portion of the curved or bent segment as compared to the linear segments.